NUCLEAR THERAPEUTICS HUB

Targeted Radiotherapies 

This hub explores radiopharmaceutical science, covering tracer development, radiolabelling and radiotheranostics to advance personalised nuclear medicine and cancer treatment.

radiolabelling organic molecules

Radiolabelling

Radiolabelling incorporates radioactive isotopes into molecules to trace biological processes and molecular pathways. It underpins drug development, metabolic research and translational nuclear medicine.

Medical radiotherapeutics use radionuclides to selectively target cancer cells

Radiotherapeutics

Radiotherapeutics uses targeted radionuclides such as actinium-225 to deliver cytotoxic radiation to malignant cells. This approach concentrates dose within tumours while limiting exposure to surrounding tissue.

Nuclear Medicine Lab With Isotopes Which Are Ready For Injection To Patient

Clinical Technologist

Clinical technologists prepare radiopharmaceuticals and operate nuclear medicine systems within regulated environments. They ensure protocol adherence, radiation safety and accurate delivery of diagnostic and therapeutic procedures.

Medical radiopharmaceuticals assist diagnosis and treatment using SPECT, PET, gamma

Radiopharmaceuticals

Radiopharmaceuticals combine biologically active molecules with radioactive isotopes for imaging and therapy. Their clinical application requires strict manufacturing controls, regulatory oversight and quality assurance.

development, preparation, and dispensing of radiopharmaceuticals

Radiopharmacy

Radiopharmacy oversees formulation, preparation and dispensing of radiopharmaceuticals for clinical use. It integrates safety procedures, sterility standards and compliance within nuclear medicine services.

Radiotheranostics combines diagnosis and therapy targeting with radiolabelled compounds

Radiotheranostics

Radiotheranostics links diagnostic imaging with targeted radionuclide therapy using related molecular agents. It enables patient selection, treatment planning and response assessment within precision oncology.

home » nuclear therapeutics hub